NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
0.5480
-0.0158 (-2.80%)
Aug 20, 2026, 2:24 PM EDT - Market open

NewGenIvf Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4.735.435.145.944.12
Revenue Growth
-13.01%5.79%-13.59%44.34%-
Cost of Revenue
3.773.613.454.413.09
Gross Profit
0.961.831.681.541.02
Selling, General & Admin
11.682.991.641.140.83
Operating Expenses
11.682.991.641.140.83
Operating Income
-10.73-1.160.040.40.2
Interest Expense
-0.62-0.78-0.05-0.08-0.09
Interest & Investment Income
00.01000
Other Non Operating Income (Expenses)
0.160.970.110.020.05
EBT Excluding Unusual Items
-11.18-0.960.110.340.16
Gain (Loss) on Sale of Investments
-0.7----
Gain (Loss) on Sale of Assets
-0.05----
Other Unusual Items
21.65----
Pretax Income
9.73-0.960.110.340.16
Income Tax Expense
--0.49-0.210.29
Earnings From Continuing Operations
9.73-0.470.110.14-0.14
Minority Interest in Earnings
0.15-0.050.020.320.14
Net Income
9.88-0.520.130.46-0
Net Income to Common
9.88-0.520.130.46-0
Net Income Growth
---71.61%--
Shares Outstanding (Basic)
0----
Shares Outstanding (Diluted)
1----
Shares Change
-----
EPS (Basic)
644.20----
EPS (Diluted)
9.12----
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.06-8.32-1.841.621.42
Free Cash Flow Per Share
-10.21----
Gross Margin
20.22%33.62%32.74%25.87%24.88%
Operating Margin
-226.95%-21.36%0.82%6.71%4.83%
Profit Margin
209.03%-9.66%2.54%7.72%-0.01%
Free Cash Flow Margin
-234.03%-153.08%-35.75%27.19%34.39%
EBITDA
-10.54-1.140.070.50.37
EBITDA Margin
-222.97%-21.00%1.43%8.40%8.88%
D&A For EBITDA
0.190.020.030.10.17
EBIT
-10.73-1.160.040.40.2
EBIT Margin
-226.95%-21.36%0.82%6.71%4.83%
Effective Tax Rate
---60.51%188.70%
SEC Filings: 10-K · 10-Q